Updating ACC preclinical models: characterization of two new patient-derived cell lines
Andrea Abate, Mariangela Tamburello, Claudia Bonera, Guido Alberto Massimo Tiberio, Sara Baldelli, Mattia Carini, Alessia Inglesi, Maria Scatolini, Deborah Cosentini, Marta Laganà, Marta Leporati, Pietro Luigi Poliani, Domenico Cosseddu, Duilio Brugnoni, Alfredo Berruti, Sandra Sigala
This paper describes the development and characterization of two new patient-derived ACC cell lines, SMAC-2 and SMAC-3, highlighting their molecular and functional features for preclinical research.
Endocrine Related Cancer · May 1, 2026Peer-reviewedPharmacology & Toxicology